Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: L-histidine (dispersible tablet): L Histidine tablet (10mg/kg ) Once daily for 12 weeks, subject aged 1-18 years
Control Intervention1: NA: NA
Sponsors
CUTIS Academy of Cutaneous Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children between age of 1-18 years 2.Confirmed diagnosis of atopic dermatitis 3.Both male and female children will be recruited 4.Parents/guardians (legally authorized representative [LAR]) willing to provide written informed consent 5.Children (age 12-17 years) willing to provide written assent
Exclusion criteria
Exclusion criteria: 1.History of any congenital anomaly (especially gastro-intestinal abnormalities) 2.History of immunosuppression due to any disease of medication 3.History of exposure to UV radiation 4.History of malnutrition 5.History of malabsorption syndrome 6.Participate in a clinical trial in last 90 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect assessed in terms of decrease in the disease activity clinically (as assessed by SCORAD Score) and subjective improvement as assessed by CHILD DLQITimepoint: After 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient compliance will be assessed based on completed patient diary and compliance assessment during study visits Safety will be assessed based on the adverse reactions reported during the study period.Timepoint: After 3 months | — |
Countries
India
Contacts
Public ContactDr Rashmi Agarwal
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed